Stock Scorecard
Stock Summary for Jasper Therapeutics Inc (JSPR) - $21.06 as of 11/20/2024 4:14:58 PM EST
Total Score
13 out of 30
Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for JSPR
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for JSPR
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for JSPR
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for JSPR
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for JSPR (25 out of 90)
| Stock Price Rating (Max of 10) | 7 |
| Historical Stock Price Rating (Max of 10) | 1 |
| Stock Price Trend (Max of 10) | 0 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 4 |
| Price to Earnings (Max of 10) | 0 |
Latest News for for JSPR
Financial Details for JSPR
Company Overview |
|
|---|---|
| Ticker | JSPR |
| Company Name | Jasper Therapeutics Inc |
| Country | USA |
| Description | N/A |
| Sector Name | REAL ESTATE & CONSTRUCTION |
| Industry Name | BLANK CHECKS |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 21.06 |
| Price 4 Years Ago | 0.00 |
| Last Day Price Updated | 11/20/2024 4:14:58 PM EST |
| Last Day Volume | 216,680 |
| Average Daily Volume | 345,003 |
| 52-Week High | 31.01 |
| 52-Week Low | 4.00 |
| Last Price to 52 Week Low | 426.50% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 117.20 |
| Sector PE | 66.35 |
| 5-Year Average PE | -11.98 |
| Free Cash Flow Ratio | 3.41 |
| Industry Free Cash Flow Ratio | 225.17 |
| Sector Free Cash Flow Ratio | 124.65 |
| Current Ratio Most Recent Quarter | 7.61 |
| Total Cash Per Share | 6.17 |
| Book Value Per Share Most Recent Quarter | 5.58 |
| Price to Book Ratio | 3.71 |
| Industry Price to Book Ratio | 7.40 |
| Sector Price to Book Ratio | 11.98 |
| Price to Sales Ratio Twelve Trailing Months | 0.00 |
| Industry Price to Sales Ratio Twelve Trailing Months | 0.47 |
| Sector Price to Sales Ratio Twelve Trailing Months | 4.06 |
| Analyst Buy Ratings | 8 |
| Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
| Total Shares Outstanding | 15,001,400 |
| Market Capitalization | 315,929,484 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -71.06% |
| Reported EPS 12 Trailing Months | -4.75 |
| Reported EPS Past Year | -3.24 |
| Reported EPS Prior Year | -1.97 |
| Net Income Twelve Trailing Months | -63,502,000 |
| Net Income Past Year | -64,465,000 |
| Net Income Prior Year | -37,685,000 |
| Quarterly Revenue Growth YOY | 0.00% |
| 5-Year Revenue Growth | 159.65% |
| Operating Margin Twelve Trailing Months | 0.00 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 92,502,000 |
| Total Cash Past Year | 86,900,000 |
| Total Cash Prior Year | 38,250,000 |
| Net Cash Position Most Recent Quarter | 92,502,000 |
| Net Cash Position Past Year | 86,882,000 |
| Long Term Debt Past Year | 18,000 |
| Long Term Debt Prior Year | 18,000 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 78,440,000 |
| Total Stockholder Equity Prior Year | 35,989,000 |
| Total Stockholder Equity Most Recent Quarter | 83,680,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -58,633,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -3.91 |
| Free Cash Flow Past Year | -52,334,000 |
| Free Cash Flow Prior Year | -46,434,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 1.29 |
| MACD Signal | 1.09 |
| 20-Day Bollinger Lower Band | 14.79 |
| 20-Day Bollinger Middle Band | 19.80 |
| 20-Day Bollinger Upper Band | 24.82 |
| Beta | 2.20 |
| RSI | 56.60 |
| 50-Day SMA | 19.28 |
| 150-Day SMA | 19.79 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 11/21/2024 4:33:16 AM EST |